The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations?
Author(s) -
Darko Kaštelan,
Ivana Kraljević,
Tina Dušek,
Nikola Knežević,
Mirsala Solak,
Bojana Gardijan,
Marko Kralik,
Tamara Poljičanin,
Tanja SkoricPolovina,
Željko Kaštelan
Publication year - 2015
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-15-0199
Subject(s) - medicine , incidentaloma , adrenocortical carcinoma , aldosterone , adrenocortical adenoma , metanephrines , subclinical infection , primary aldosteronism , pheochromocytoma , adenoma , malignancy , radiology
The current guidelines for the management of adrenal incidentaloma advise hormonal and radiological follow-up of patients for 2-5 years after the initial diagnosis. However, the vast majority of adrenal incidentaloma are non-functional benign cortical adenomas that require no treatment, so the routine application of the current strategies often results in a number of unnecessary biochemical and radiological investigations. The aim of this study was to analyse the clinical course of patients with adrenal incidentaloma and to provide a critical review of the current management strategy of the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom